Developing Countries: Malaria

International Development written question – answered on 25th January 2010.

Alert me about debates like this

Photo of William Bain William Bain Labour, Glasgow North East

To ask the Secretary of State for International Development what steps his Department is taking to assist the development of a safe, effective and affordable malaria vaccine.

Photo of Michael Foster Michael Foster Parliamentary Under-Secretary, Department for International Development

The Department for International Development (DFID) supports malaria vaccine development through the European and Developing Country Clinical Trials Partnership (EDCTP). To date EDCTP has provided €20 million for malaria vaccine development, funding high quality clinical trials to accelerate the process of vaccine development. These trials are necessary to ensure that safe vaccines go beyond discovery and actually enter the market in developing countries.

DFID also supports the Advance Market Commitment (AMC). This funding mechanism, launched by the Prime Minister at the G8 summit, commits governments to fund agreed volumes of as yet unavailable vaccines, at an agreed price, if a product is successfully developed. The first AMC is funding the pneumococcal vaccine. The DFID White Paper, 'Eliminating World Poverty: Building our common future', makes a commitment to consider the funding of malaria vaccine as a possible future AMC.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.